Trials / Unknown
UnknownNCT05396092
The Effects of an Integrated Mindfulness-based Tai Chi Chuan Program on Sleep Disturbance Among Community-dwelling Elderly People
The Effects of an Integrated Mindfulness-based Tai Chi Chuan Program on Sleep Disturbance Among Community-dwelling Elderly People: A Randomized Controlled Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 256 (estimated)
- Sponsor
- The Hong Kong Polytechnic University · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
The trial aims to evaluate the effects of an integrated form of mindfulness-based Tai Chi Chuan (MBTCC) program and the underlying mechanisms of the beneficial effects on sleep disturbance over 12-month follow-up in community-dwelling elderly people.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Integrated mindfulness-based Tai Chi Chuan | MBTCC will integrate components from both the MBI and TCC groups. The entire intervention consists of eight weekly sessions of two-and-a-half to three hours each. |
| BEHAVIORAL | Mindfulness-based intervention | The MBI group is mainly based on the basic theory and research of the foundational mindfulness-based stress reduction program. The intervention consists of eight weekly sessions of two to two-and-a-half hours each. |
| BEHAVIORAL | Tai Chi Chuan | TCC is mainly based on a nine-form Yang-style form of TCC, which is a brief and modified version of 64-form Yang-style TCC. The entire intervention consists of eight weekly sessions of two to two-and-a-half hours each. |
| BEHAVIORAL | Sleep Hygiene Education | SHE is based on principles used in stimulus control and sleep hygiene education, which has previously been used as the control group in sleep-related research. The entire intervention consists of eight weekly sessions of two to two-and-a-half hours each. |
Timeline
- Start date
- 2022-04-19
- Primary completion
- 2025-04-18
- Completion
- 2025-04-18
- First posted
- 2022-05-31
- Last updated
- 2022-05-31
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT05396092. Inclusion in this directory is not an endorsement.